Wart Remover
Over-the-CounterHandelsnamen: VERUCIDE WART REMOVER Kit
About This Medication
Topical treatment that gradually breaks down and removes common warts on hands and feet.
Indikationen und Anwendung
Dosierung und Verabreichung
Warnhinweise und Vorsichtsmaßnahmen
Warnings - For external use only (for step 1 & 2) Extremely flammable. Keep away from fire or flames
Frequently Asked Questions
Uses ■ (for step 1) Antiseptic to decrease bacteria on the skin ■ (for step 2) For the removal of common warts. The common wart is easily recognized by the rough “cauliflower-like” appearance of the surface ■ For the removal of plantar warts on the bottom of the foot. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern
Directions ■ (for step 1) Wash the affected area with one or two drops ■ ( for step 2) Clean using step 1 and allow area to dry. Apply a small amount at a time with applicator to sufficiently cover each wart and let dry ■ Let dry ■ Repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks
Warnings - For external use only (for step 1 & 2) Extremely flammable. Keep away from fire or flames
Wart Remover is available over the counter (OTC) without a prescription.
Similar Other Products
Browse all Other products →References & Data Sources
- • DailyMed — Wart Remover drug label (National Library of Medicine)
- • openFDA — Wart Remover label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 312881 (NLM Normalized Drug Names)
- • NDC Directory — Wart Remover (FDA National Drug Code)
Medizinischer Haftungsausschluss
Die Informationen auf dieser Seite dienen ausschließlich zu Bildungszwecken und sollten nicht als Ersatz für professionellen ärztlichen Rat, Diagnose oder Behandlung verwendet werden.
Wenden Sie sich bei Fragen zu einem medizinischen Zustand oder einem Arzneimittel stets an Ihren Arzt oder einen anderen qualifizierten Angehörigen der Gesundheitsberufe.
Datenquellen: DailyMed (NLM), openFDA, MFDS